BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2311792)

  • 1. [Prolonging transplant survival time by PUVA treatment of the transplant recipient. Significance of cis-urocanic acid].
    Gruner S; Stoppe H; Eckert R; Sönnichsen N; Diezel W
    Dermatol Monatsschr; 1990; 176(1):49-54. PubMed ID: 2311792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of rat heart allograft rejection by a PUVA treatment of the graft recipient. Role of cisurocanic acid.
    Oesterwitz H; Gruner S; Diezel W; Schneider W
    Transpl Int; 1990 May; 3(1):8-11. PubMed ID: 2369484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of skin allograft rejection and acute graft-versus-host disease by cis-urocanic acid.
    Gruner S; Diezel W; Stoppe H; Oesterwitz H; Henke W
    J Invest Dermatol; 1992 Apr; 98(4):459-62. PubMed ID: 1548429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cis-urocanic acid as a mediator of ultraviolet-light-induced immunosuppression.
    Gruner S; Oesterwitz H; Stoppe H; Henke W; Eckert R; Sönnichsen N
    Semin Hematol; 1992 Apr; 29(2):102-7. PubMed ID: 1594941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of a transfusion of donor leukocytes treated with 8-methoxypsoralen and long-wave ultraviolet light (PUVA) on skin allograft survival in mice.
    Gruner S; Noack F; Meffert H
    Biomed Biochim Acta; 1989; 48(7):477-85. PubMed ID: 2803285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of urocanic acid isomers in murine skin during development and after irradiation with UVB light.
    Norval M; McIntyre CR; Simpson TJ; Howie SE; Bardshiri E
    Photodermatol; 1988 Aug; 5(4):179-86. PubMed ID: 2852797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of rat heart and kidney allograft rejection by photochemical treatment of the recipient].
    Oesterwitz H; Gruner S; Schneider W
    Z Exp Chir Transplant Kunstliche Organe; 1990; 23(4):199-201. PubMed ID: 2095643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of survival of small bowel transplant recipients after treatment with cis-urocanic acid.
    Gieseler RK; Klemp F; Bredt M; Mentlein R; Kuhn R; von Gaudecker B; Peters JH; Schlemminger R
    Transplant Proc; 1994 Jun; 26(3):1601-3. PubMed ID: 8030054
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prolongation of transplantation survival time by a PUVA treatment. Experimental and clinical results].
    Gruner S; Oesterwitz H; Kaden J; Meffert H
    Z Exp Chir Transplant Kunstliche Organe; 1990; 23(1):32-4. PubMed ID: 2220001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cis-Urocanic acid does not inhibit mitogen induced lymphocyte transformation in man.
    Higaki Y; Hauser C; Siegenthaler G; Saurat JH
    Acta Derm Venereol; 1986; 66(6):523-6. PubMed ID: 2433874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extending the survival time of allogenic rat kidney transplants by PUVA treatment of the recipient].
    Oesterwitz H; Gruner S; Schneider W
    Z Urol Nephrol; 1990 Jan; 83(1):13-6. PubMed ID: 2330760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of a monoclonal antibody to cis-urocanic acid on the suppression of delayed and contact hypersensitivity following ultraviolet irradiation.
    Moodycliffe AM; Bucana CD; Kripke ML; Norval M; Ullrich SE
    J Immunol; 1996 Oct; 157(7):2891-9. PubMed ID: 8816394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo treatment of mice with heat shock protein, gp 96, improves survival of skin grafts with minor and major antigenic disparity.
    Kovalchin JT; Mendonca C; Wagh MS; Wang R; Chandawarkar RY
    Transpl Immunol; 2006 Jan; 15(3):179-85. PubMed ID: 16431284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereospecific inhibition of human epidermal cell interleukin-1 secretion and HLA-DR expression by cis-urocanic acid.
    Räsänen L; Jansén CT; Reunala T; Morrison H
    Photodermatol; 1987 Aug; 4(4):182-6. PubMed ID: 3501579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The degradation of L-histidine and trans- and cis-urocanic acid by bacteria from skin and the role of bacterial cis-urocanic acid isomerase.
    Hug DH; Dunkerson DD; Hunter JK
    J Photochem Photobiol B; 1999 May; 50(1):66-73. PubMed ID: 10443033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urocanic acid as an immunosuppressant in allotransplantation in mice.
    Guymer RH; Mandel TE
    Transplantation; 1993 Jan; 55(1):36-43. PubMed ID: 8420062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cis-urocanic acid in UVB-induced suppression of contact hypersensitivity.
    Kondo S; Sauder DN; McKenzie RC; Fujisawa H; Shivji GM; El-Ghorr A; Norval M
    Immunol Lett; 1995 Dec; 48(3):181-6. PubMed ID: 8867849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a monoclonal antibody to cis-urocanic acid: detection of cis-urocanic acid in the serum of irradiated mice by immunoassay.
    Moodycliffe AM; Norval M; Kimber I; Simpson TJ
    Immunology; 1993 Aug; 79(4):667-72. PubMed ID: 8406594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of contact hypersensitivity by short-term ultraviolet irradiation: II. The role of urocanic acid.
    Harriott-Smith TG; Halliday WJ
    Clin Exp Immunol; 1988 Apr; 72(1):174-7. PubMed ID: 3396218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urocanic acid and its role in the photoimmunomodulation process].
    Malina L
    Cas Lek Cesk; 2003 Aug; 142(8):470-3. PubMed ID: 14626561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.